Synovus Financial’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Synovus Financial’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-58,000	Closed	-$7.55K	–	864
2023 Q1	$7.55K	Buy	58,000 +34,717	+149%	+$7.06K	﹤0.01%	826
2022 Q4	$3.82K	Buy	+23,283	New	+$9.7K	﹤0.01%	859

Other funds holding PLXP

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Synovus Financial's PLXP Position: Q2 2023 in Review

Synovus Financial sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 58,000 shares — an estimated $7.55K sold.

Synovus Financial first reported a position in PLXP in Q4 2022 and held it in 2 quarters. The position peaked at $7.55K in Q1 2023. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Synovus Financial reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Synovus Financial sold 58,000 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $7.55K.
Synovus Financial first reported a position in PLx Pharma Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Synovus Financial's PLx Pharma Inc. Common Stock position peaked at $7.55K in Q1 2023.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Synovus Financial's 13F filing for Q2 2023, filed 8 Aug 2023.